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THE EPIDERMIS AND CYCLIC AMP
A hormone induces a rapid and profound change in the metabolic balance of its target organ. Early
studies emphasized the extraordinarily low concentrations in which many hormones are effective. The
fact that catechoiamines and polypeptides are frequently unable to penetrate the surface of cells made
this seem all the more remarkable. The mechanism of their action, which for many years remained a
central problem of molecular biology, was finally resolved by the discovery of adenosine 3',5'-
monophosphate (cyclic AMP) in 1958 by Sutherland & Rail. It subsequently became apparent that
cyclic AMP was the intracellular second messenger for those hormones that by themselves could not
penetrate inside the cell.
An overall but abbreviated sequence of events is shown in Fig. i. When activated by cyclic AMP,
a cyclic AMP dependent protein kinase may phosphorylate many different proteins, both enzymatic
and structural. In some cases this results in their activation, whereas in others the protein is converted
to a biologically inactive form. Thus, co-ordinate control over several different pathways is accom-
plished. In addition, the amplification obtained by linking enzymic reactions in cascade is consider-
able; one may visualize how a cell could respond to a very few molecules of the external hormone
(the 'first messenger'). The most comprehensive review of the general literature is the monograph of
Robison, Butcher & Sutherland (1971), which includes a bibliography of over 1500 references to
cyclic AMP. It is notable but not surprising that this literature deals with almost every mammalian
tissue except epidermis.
Does the 'second messenger' system in fact operate in mammalian epidermis ? Adenylate cyclase
activity was first described in homogenates of whole guinea-pig skin (Mier & Urselmann, 1970a),
but no hormonal stimulation could be demonstrated. Using a particulate fraction isolated from epider-
mis, Duell et ah (1971) and Marks & Rebien (1972a) were able to show some degree of stimulation by
catechoiamines, although this was still very small compared with other tissues. Intact epidermal cells,
on the other hand, respond vigorously; for example, Powell, Duell & Voorhees (1971) found a three-
fold increase in the cyclic AMP content of rat epidermis following exposure to isoproterenol, and
Bronstad, Elgjo and 0ye (1971) reported increases of more than ten-fold in the synthesis of cyclic
AMP by whole hamster skin in response to adrenalin. Thus, it is now clear that this part, at least, of
the system is functional
The other two enzymes shown in Fig. r have now also been described in mammalian skin. The
enzyme responsible for lowering cellular levels of cyclic AMP after hormonal stimulation has ceased,
cyclic AMP phosphodiesterase, was examined in whole mouse skin (Mier & Urselmann, 1972) and
found to have a Kn, of 9 x I O ' ^ M and was inhibited by methyl xanthines. The high K ,̂ cyclic
AMP phosphodiesterase has been measured in both involved and uninvolved psoriasis epithelium and
appears to be unaltered (Voorhees et al.y 1973a). The low K ,̂ aaivity might be increased in the lesion
in comparison to the uninvolved areas (Voorhees et ah, 1974a). Cychc AMP dependent protein kinase
has been investigated in whole human skin (Kumar, Tao & Solomon, 1971), in whole mouse skin
(Mier & van den Hurk, 1972) and in human epidermis (Voorhees et al., 1974b); the cutaneous
enzyme seems very similar to those from other tissues. Although certain of these results pertain to
whole skin, the preponderance of epidermal cells in such preparations and the demonstration of all












FIGURE I. The 'cyclic AMP cascade'. Both enzymatic and structural proteins may be phosphory-
lated by the cyclic AMP-dcpendcnt protein kinase.
reasonable to conclude that epidermis is indeed equipped with a complete 'second messenger'
system.
But what 'message' does this system carry ? The activity of many internal tissues must be linked to
the minute-to-minute needs of the body as a whole; since epidermis (as far as we ktiow) does not
secrete metabolites vital to other organs, it is more difficult to understand the need for such con-
tinuous hormonal supervision. What epidermis does provide, however, is a highly specialized barrier
between the 'inside' and the 'outside'. An important parameter, therefore, is its thickness; one must
presume the existence of a homeostatic device to balance the proliferative rate of the basal cells with the
rate of desquamation from the surface. This homeostasis has been studied extensively by Bullough,
who introduced the now familiar concept of the epidermal chalone (Bullough, 1962). In the course of
this work it was established that catecholamines are powerful inhibitors of epidermal cell division.
Voorhees & Duell (1971) proposed that cyclic AMP mediates this catecholamine induced inhibition
of proliferation. This hypothesis not only assigns a physiological function to the 'second messenger'
in epidermis, but also explains (via the activation of glycogen synthetase and the inactivation of
glycogen phosphorylase) (Fig. 2) why an accumulation of glycogen generally accompanies enhanced
epidermal proliferation. In essence, the Voorhees-Duell hypothesis suggests that cyclic AMP is a
major regulator (not necessarily the only one) of epidermal thickness and function. However, which
hormone, if any, modulates intraepidermal cyclic AMP levels is unknown. The experimental support
for this hypothesis is now considerable, and includes the following observations:
(t) In vitro studies have shown that cyclic AMP directly inhibits epidermal cell division in a dose-
dependent manner (Marks & Rebien, 1972b; Voorhees, Duell & Kelsey, 1972). In fact, the four
criteria of Robison et al. (1971) of a cyclic AMP mediated event (inhibition of epidermal cell division)
have been met (Voorhees et al., 1973a).
(2) In rapidly dividing epithelium, such as the psoriatic plaque, the level of cyclic AMP in vivo
is decreased (Voorhees et al.., t972).
(3) The degree of activation of phosphorylase (Mier & van den Hurk, 1974) has been reported as
lower than normal in the psoriatic plaque.
(4) Wright et al. (1973) claim to have found a reduced rate of cyclic AMP synthesis in the psoriatic
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FtGURE 2. Control of glycogen metabolism via the activation of protein kinase. Most of the com-
ponents of this pathway have now been demonstrated in epidermis.
plaque. This may be the case but requires further work and confirmation, as discussed by Voorhees
et al. (1973a).
Can the pathogenesis of any of the familiar dermatoses be related to a defective 'second messenger'
system ? So far two hypothesis have been offered. The earlier of these was the attempt by Szentivanyi
(1968) to describe the clinical manifestations of atopy in such terms. Despite considerable circum-
stantial evidence in support of this idea, direct measurements of the three enzymes concerned (Fig.
i) in four to six patients have failed to reveal any abnormality (Mier & Urselmann, 1970b; Holla et al.,
1972; Mier et al., 1972). Although the enzyme activities are apparently normal in vitro, any final
conclusions must await study of factors which may interfere with the function of these enzymes in
vivo and the study of the adenylate cyclase receptors at the cell surface.
The more recent, and more promising, line of thought relates to psoriasis. The original suggestion
of a defective cyclic AMP cascade in this disease was made by Voorhees & Duell (1971). As we have
already pointed out, subsequent reports seem to support this notion that both the high prolifer-
ative rate and the accumulation of glycogen in the psoriatic lesion are due to a co-ordinate mis-
regulation occasioned by reduced cyclic AMP levels. This provides an important new link in the
pathogenic chain, but in no sense tells us the 'primary cause' of the disease. It would, of course, be
tempting to equate the familial predisposition to psoriasis with an inherited abnormality of adenylate
cyclase, cyclic AMP phosphodiesterase or the adenylate cyclase receptor. Current evidence, however,
suggests that the disturbed cyclic AMP balance may be secondary to some other process—an inhi-
bition of adenylate cyclase function or a stimulation of cyclic AMP phosphodiesterase in vivo without
a major genetic defect in either enzyme (Voorhees et al., 1973a).
In conclusion, it is perhaps pertinent to comment that the io-year lag which has been customary
before new 'scientific' thought is assimilated into dermatology seems at last to be diminishing. Skin is
finally becoming an acceptable tissue for molecular biologists to investigate, and clinicians are becom-
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ing more aware that an understanding of many diseases in sufficient depth to lead to better therapy is
possible only in molecular terms. If this trend continues, the following decade will be an exciting one
for us all. Perhaps the most intriguing line of investigation in this area at the present time is the
interrelation between cyclic AMP and cyclic GMP in epidermal physiology (Voorhees ei al., 1973a,
1973b; Voorhees et ai, 1974a, 1974b). The role of cyclic GMP in epidermal homeostasis will be the
subject of a future commentary.
University of Michigan Medical School, J.J. VOORHEES
Ann Arbor, Michigan,
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